Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics

scientific article published on 01 May 2019

Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1178221819844205
P932PMC publication ID6495438
P698PubMed publication ID31068753

P50authorChengwen TengQ59543001
P2093author name stringChristopher R Frei
John Hakim
Kirk E Evoy
Brian Frescas
Stephen Saklad
Victor G Encarnacion
P2860cites workUse of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsQ34112790
Emergency Department Visits Involving Misuse and Abuse of the Antipsychotic Quetiapine: Results from the Drug Abuse Warning Network (DAWN)Q35647935
Quetiapine: treatment for substance abuse and drug of abuseQ37116604
Quantitative signal detection using spontaneous ADR reportingQ37439662
Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics.Q37638936
A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile.Q39434182
Olanzapine abuse was relieved after switching to aripiprazole in a patient with psychotic depression.Q42944127
Evaluation of quetiapine abuse and misuse reported to poison centersQ45002147
Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' DatabaseQ47359368
A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychoticsQ48474995
Increasing rates of quetiapine overdose, misuse, and mortality in Victoria, AustraliaQ88358600
The FDA and the Next Wave of Drug Abuse - Proactive PharmacovigilanceQ88918943
P407language of work or nameEnglishQ1860
P921main subjectquetiapineQ408535
aripiprazoleQ411188
FDA Adverse Event Reporting SystemQ4686710
Prescription Drug AbuseQ59597078
P304page(s)1178221819844205
P577publication date2019-05-01
P1433published inSubstance Abuse: Research and TreatmentQ15766459
P1476titleComparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics
P478volume13

Reverse relations

Q89804908Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Databasecites workP2860

Search more.